|
1
|
Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys.
|
Lancet
|
2006
|
12.04
|
|
2
|
Identification of loci associated with schizophrenia by genome-wide association and follow-up.
|
Nat Genet
|
2008
|
10.52
|
|
3
|
Interventions for basal cell carcinoma of the skin: systematic review.
|
BMJ
|
2004
|
2.00
|
|
4
|
Randomized clinical trials for psoriasis 1977-2000: the EDEN survey.
|
J Invest Dermatol
|
2003
|
1.77
|
|
5
|
Full genome screen for Alzheimer disease: stage II analysis.
|
Am J Med Genet
|
2002
|
1.77
|
|
6
|
Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg: results of the UK Dermatology Clinical Trials Network's PATCH II trial.
|
Br J Dermatol
|
2011
|
1.63
|
|
7
|
No major schizophrenia locus detected on chromosome 1q in a large multicenter sample.
|
Science
|
2002
|
1.57
|
|
8
|
Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13.
|
Arch Gen Psychiatry
|
2005
|
1.48
|
|
9
|
Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia.
|
Arch Gen Psychiatry
|
2010
|
1.46
|
|
10
|
Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting.
|
Allergy
|
2012
|
1.41
|
|
11
|
Low efficacy of mebendazole against hookworm in Vietnam: two randomized controlled trials.
|
Am J Trop Med Hyg
|
2007
|
1.38
|
|
12
|
Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia.
|
Proc Natl Acad Sci U S A
|
2006
|
1.25
|
|
13
|
Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease.
|
Am J Med Genet B Neuropsychiatr Genet
|
2005
|
1.22
|
|
14
|
Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder.
|
Arch Gen Psychiatry
|
2006
|
1.19
|
|
15
|
Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use.
|
Br J Psychiatry
|
2007
|
1.19
|
|
16
|
Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring?
|
J Invest Dermatol
|
2003
|
1.16
|
|
17
|
The reporting of observational research studies in dermatology journals: a literature-based study.
|
Arch Dermatol
|
2010
|
1.14
|
|
18
|
New treatments for atopic dermatitis.
|
BMJ
|
2002
|
1.11
|
|
19
|
How atopic is atopic dermatitis?
|
J Allergy Clin Immunol
|
2004
|
1.10
|
|
20
|
Measuring atopic eczema severity visually: which variables are most important to patients?
|
Arch Dermatol
|
2005
|
1.08
|
|
21
|
Strong evidence that GNB1L is associated with schizophrenia.
|
Hum Mol Genet
|
2007
|
1.07
|
|
22
|
Poor sanitation and helminth infection protect against skin sensitization in Vietnamese children: A cross-sectional study.
|
J Allergy Clin Immunol
|
2006
|
1.07
|
|
23
|
Impact of a multimedia intervention "Skinsafe" on patients' knowledge and protective behaviors.
|
Prev Med
|
2006
|
1.05
|
|
24
|
Early life risk factors for atopic dermatitis in Ethiopian children.
|
J Allergy Clin Immunol
|
2005
|
1.00
|
|
25
|
Development of Raman microspectroscopy for automated detection and imaging of basal cell carcinoma.
|
J Biomed Opt
|
2009
|
0.96
|
|
26
|
Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects.
|
Arch Gen Psychiatry
|
2009
|
0.94
|
|
27
|
Do fast foods cause asthma, rhinoconjunctivitis and eczema? Global findings from the International Study of Asthma and Allergies in Childhood (ISAAC) phase three.
|
Thorax
|
2013
|
0.93
|
|
28
|
The use of corticosteroids and corticosteroid phobia in atopic dermatitis.
|
Clin Dermatol
|
2003
|
0.92
|
|
29
|
Analysis of ProDH, COMT and ZDHHC8 risk variants does not support individual or interactive effects on schizophrenia susceptibility.
|
Schizophr Res
|
2006
|
0.86
|
|
30
|
Rapid acquisition of Raman spectral maps through minimal sampling: applications in tissue imaging.
|
J Biophotonics
|
2011
|
0.85
|
|
31
|
A family based study implicates solute carrier family 1-member 3 (SLC1A3) gene in attention-deficit/hyperactivity disorder.
|
Biol Psychiatry
|
2005
|
0.81
|
|
32
|
ARVCF genetic influences on neurocognitive and neuroanatomical intermediate phenotypes in Chinese patients with schizophrenia.
|
J Clin Psychiatry
|
2011
|
0.81
|
|
33
|
Medical justice for undocumented migrants.
|
Lancet
|
2008
|
0.81
|
|
34
|
Evidence-Based Dermatology: Everyone's Business.
|
Am J Clin Dermatol
|
2011
|
0.80
|
|
35
|
Genome-wide supported psychosis risk variant in ZNF804A gene and impact on cortico-limbic WM integrity in schizophrenia.
|
Am J Med Genet B Neuropsychiatr Genet
|
2012
|
0.80
|
|
36
|
Psycho-education with problem solving (PEPS) therapy for adults with personality disorder: a pragmatic multi-site community-based randomised clinical trial.
|
Trials
|
2011
|
0.80
|
|
37
|
Appraising systematic reviews and meta-analyses.
|
Arch Dermatol
|
2003
|
0.78
|
|
38
|
A multi-centre randomised controlled trial of rehabilitation aimed at improving outdoor mobility for people after stroke: study protocol for a randomised controlled trial.
|
Trials
|
2012
|
0.78
|
|
39
|
Analysis of neurogranin (NRGN) in schizophrenia.
|
Am J Med Genet B Neuropsychiatr Genet
|
2011
|
0.77
|
|
40
|
"Objective" measures of atopic dermatitis severity: in search of the holy Grail.
|
Arch Dermatol
|
2003
|
0.77
|
|
41
|
Emollients, education and quality of life: the RCPCH care pathway for children with eczema.
|
Arch Dis Child
|
2011
|
0.77
|
|
42
|
Role of immunoglobulin E sensitization in eczema, previously referred to as atopic dermatitis.
|
Expert Rev Clin Immunol
|
2005
|
0.77
|
|
43
|
The Cochrane Skin Group: promoting the best evidence.
|
J Cutan Med Surg
|
2005
|
0.76
|
|
44
|
Analysis of copy number variation using quantitative interspecies competitive PCR.
|
Nucleic Acids Res
|
2008
|
0.76
|
|
45
|
A win-win proposition: fostering US health care consumer involvement in the Cochrane Collaboration Skin Group.
|
J Am Acad Dermatol
|
2005
|
0.76
|
|
46
|
Prevention of hand dermatitis in bakers' apprentices: different efficacy of skin protection measures and UVB hardening.
|
Int Arch Occup Environ Health
|
2002
|
0.76
|
|
47
|
Feasibility, double-blind, randomised, placebo-controlled, multi-centre trial of hand-held NB-UVB phototherapy for the treatment of vitiligo at home (HI-Light trial: Home Intervention of Light therapy).
|
Trials
|
2014
|
0.75
|
|
48
|
Skin protection in bakers' apprentices.
|
Contact Dermatitis
|
2002
|
0.75
|
|
49
|
Products in "Bounty bags" potentially harm newborn skin.
|
BMJ
|
2013
|
0.75
|
|
50
|
Adalimumab vs methotrexate for the treatment of chronic plaque psoriasis.
|
Arch Dermatol
|
2009
|
0.75
|
|
51
|
Is leflunomide effective in the treatment of psoriasis in a patient who is unable to benefit from standard first- and second-line therapies and needs an affordable treatment option?
|
Arch Dermatol
|
2008
|
0.75
|
|
52
|
Implications for Research: Getting the Most out of Cochrane Reviews.
|
Cochrane Database Syst Rev
|
2011
|
0.75
|